Evaluation of Salivary Chemerin and Visfatin in Relation to Periodontitis and Obesity

Farah Razak Abood; Zainab A. Aldhaher

doi:10.30526/38.2.3650

Authors

Farah Razak Abood Department of Basic Science, College of Dentistry, University of Baghdad, Baghdad, Iraq. https://orcid.org/0009-0007-0322-4228
Zainab A. Aldhaher Department of Basic Science, College of Dentistry, University of Baghdad, Baghdad, Iraq. https://orcid.org/0000-0002-8977-8761

DOI:

https://doi.org/10.30526/38.2.3650

Keywords:

Chemerin, Visfatin, Obesity, Periodontitis

Abstract

Periodontitis is a common disorder caused by imbalanced plaque biofilms and associated with gradual deterioration of the teeth supporting apparatus. Obesity is documented as a significant health concern and considered a primary risk factor for the progression of many diseases, such as hypertension, diabetes, malignancies, and periodontitis. Proinflammatory cytokines released in response to these health conditions are of great importance and establish the link between diagnosis and treatment. The present study was conducted to assess levels of chemerin and visfatin in saliva and to evaluate the impact of obesity on periodontitis. Ninety participants were included in the study and dived into three groups: (Group I: obese and periodontitis patients, n = 30), (Group II: periodontitis patients, n = 30) and (Group III: healthy controls, n = 30). We selected all participants based on their BMI measurement and examination of periodontal parameters. Unstimulated saliva was the obtained sample for evaluation of chemerin and visfatin using the ELISA technique. The study results found that chemerin and visfatin levels were different among study groups, but group I members have the highest levels, followed by group II and group III. In conclusion, obesity has a high impact on periodontitis through the expression of proinflammatory biomarkers in saliva like adipokines (cytokines produced by adipose tissue).

Author Biographies

Farah Razak Abood, Department of Basic Science, College of Dentistry, University of Baghdad, Baghdad, Iraq.

Department of Basic Science, College of Dentistry, University of Baghdad, Baghdad, Iraq.
Zainab A. Aldhaher, Department of Basic Science, College of Dentistry, University of Baghdad, Baghdad, Iraq.

Department of Basic Science, College of Dentistry, University of Baghdad, Baghdad, Iraq.

References

1. Jiao J, Jing W, Si Y, Feng X, Tai B, Hu D. The prevalence and severity of periodontal disease in Mainland China: Data from the Fourth National Oral Health Survey (2015–2016). J Clin Periodontol. 2021;48(2):168-79. https://doi.org/10.1111/jcpe.13390.

2. Hajishengallis G, Chavakis T, Lambris JD. Current understanding of periodontal disease pathogenesis and targets for host‐modulation therapy. Periodontol 2000. 2020;84(1):14-34. https://doi.org/10.1111/prd.12332.

3. Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-98. https://doi.org/10.1038/s41574-019-0176-8.

4. Pamuk F, Kantarci A. Inflammation as a link between periodontal disease and obesity. Periodontol 2000. 2022;90(1):186-96. https://doi.org/10.1111/prd.12417.

5. Maciel SS, Feres M, Gonçalves TE, Zimmermann GS, da Silva HD, Figueiredo LC. Does obesity influence the subgingival microbiota composition in periodontal health and disease?. J Clin Periodontol. 2016;43(12):1003-12. https://doi.org/10.1111/jcpe.12610.

6. Huck O, Buduneli N, Bravo D. Inflammatory mediators in periodontal pathogenesis. Mediators Inflamm. 2019;2019:1-3. https://doi.org/10.1155/2019/2019.

7. Mahmood MS, Abdulmajeed SM. Chemerin as a Biomarker for Periodontitis in Systemically Healthy and Type 2 Diabetic Patients. Mustansiria Dent J. 2022;18(2). https://doi.org/10.26477/mdj.v18i2.2360.

8. Cetiner D, Uraz A, Öztoprak S, Akça G. The role of visfatin levels in gingival crevicular fluid as a potential biomarker in the relationship between obesity and periodontal disease. J Appl Oral Sci. 2019;27:1-9. https://doi.org/10.1590/1678-7757-2018-0545.

9. Al-Ghurabi BH. The Role of Soluble TLR-2 in the Immunopathogenesis of Gingivitis. Int Med J. 2021;28(1):37-9. https://doi.org/10.5281/zenodo.4923911.

10. World Health Organization. Obesity and Overweight; 2018. https://doi.org/10.1093/ije/dyy065.

11. Newman MG, Takei H, Klokkevold PR, Carranza FA. Carranza's Clinical Periodontology. Elsevier Health Sciences; 2011.

12. Navazesh M, Kumar SK. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc. 2008;139:35S-40S. https://doi.org/10.14219/jada.archive.2008.0353.

13. Jepsen S, Suvan J, Deschner J. The association of periodontal diseases with metabolic syndrome and obesity. Periodontol 2000. 2020;83(1):125-53. https://doi.org/10.1111/prd.12286.

14. Gul SS, Imran NK, Al-Sharqi AJ, Abdulkareem AA. Association of overweight/obesity with the severity of periodontitis using BPE code in an Iraqi population. Clin Epidemiol Glob Health. 2021;9:21-5. https://doi.org/10.1016/j.cegh.2020.07.003.

15. Ali BT, Mahmood MS. Assessment of Salivary Total Antioxidants Capacity Levels of Patients with Chronic Periodontitis in Comparison to Healthy Control. J Baghdad Coll Dent. 2018;30(1):58-62. https://doi.org/10.26477/jbcd.v30i1.1465.

16. Nanakaly HT. Interleukin-6 level in saliva of patients with chronic periodontitis: A case-control study. J Baghdad Coll Dent. 2016;325(3154):1-6. https://doi.org/10.26477/jbcd.v325i3154.1576.

17. Aziz AR, Mohammed AT. The salivary inflammatory biomarkers (Interleukin-6, C-reactive protein) in relation with caries-experience among a group of 12-year-old obese boys. J Baghdad Coll Dent. 2016;28(1):138-42. https://doi.org/10.26477/jbcd.v28i1.1234.

18. Abdullameer MA, Abdulkareem AA. Diagnostic potential of salivary interleukin‐17, RANKL, and OPG to differentiate between periodontal health and disease and discriminate stable and unstable periodontitis: A case‐control study. Health Sci Rep. 2023;6(2):e1103. https://doi.org/10.1002/hsr2.1103.

19. Rajasekar A. Correlation of salivary visfatin levels in obese and non-obese population with periodontal status. J Oral Biol Craniofac Res. 2023;13(1):67-70. https://doi.org/10.1016/j.jobcr.2022.11.002.

20. Mourouzis K, Oikonomou E, Siasos G, Tsalamadris S, Vogiatzi G, Antonopoulos A. Pro-inflammatory cytokines in acute coronary syndromes. Curr Pharm Des. 2020;26(36):4624-47. https://doi.org/10.2174/1381612826666200916121048.

21. Ramos‐Junior ES, Leite GA, Carmo‐Silva CC, Taira TM, Neves KB, Colón DF. Adipokine chemerin bridges metabolic dyslipidemia and alveolar bone loss in mice. J Bone Miner Res. 2017;32(5):974-84. https://doi.org/10.1002/jbmr.3076.

22. Özcan E, Saygun NI, Serdar MA, Kurt N. Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation. Clin Oral Investig. 2015;19:921-8. https://doi.org/10.1007/s00784-014-1291-9.

23. Mahmood MS, Omer BR. Correlation between Visfatin and Creatine Kinase Levels with Periodontal Health Status of Patients with Coronary Atherosclerosis and Chronic Periodontitis. J Baghdad Coll Dent. 2016;28(3):121. https://doi.org/10.26477/jbcd.v28i3.1036.

24. Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis?. J Clin Periodontol. 2011;38:60-84. https://doi.org/10.1111/j.1600-051X.2010.01671.x.

25. Tabari ZA, Azadmehr A, Nohekhan A, Naddafpour N, Ghaedi FB. Salivary visfatin concentrations in patients with chronic periodontitis. J Periodontol. 2014;85(8):1081-5. https://doi.org/10.1902/jop.2014.130652.

26. Pradeep AR, Raghavendra NM, Prasad MR, Kathariya R, Patel SP, Sharma A. Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease. J Periodontol. 2011;82(9):1314-9. https://doi.org/10.1902/jop.2011.100645.

27. Yilmaz M, Bal İ, Hanli S, Turkmen E, Balci N, Toygar HU. Annexin levels in GCF determine the imbalance of periodontal inflammatory regulation. Scient Report. 2024;14(1): 28833.‏ https://doi.org/10.1038/s41598-024-80418-x.

28. Sree M, Rao R, Manoranjan SJ, Ranganath V. Comparative evaluation of chemerin and visfatin levels in saliva of patients with chronic periodontitis and type-2 diabetes mellitus: a clinicobiochemical study. RGUHS J Med Sci. 2022;12(4). https://doi.org/10.55627/rjm.2022.12.4.5.

29. Ismail H, Pathak AK, Lal N, Rastogi P, Ahmad K, Khan MA. Effect of non-surgical periodontal therapy on salivary and gingival crevicular fluid concentration of visfatin in periodontal health and disease. J Oral Biol Craniofac Res. 2024;14(4):430-434. https://doi.org/10.1016/j.jobcr.2024.04.010.